Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.0%
5Y CAGR+67.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+31.0%/yr
vs +187.2%/yr prior
5Y CAGR
+67.4%/yr
Recent deceleration
Acceleration
-156.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
13.1x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $274.55M | +19.7% |
| 2024 | $229.39M | +23.9% |
| 2023 | $185.15M | +51.6% |
| 2022 | $122.12M | +100.3% |
| 2021 | $60.97M | +192.0% |
| 2020 | $20.88M | +225.5% |
| 2019 | $6.42M | +257.4% |
| 2018 | $1.79M | +158.3% |
| 2017 | $695000.00 | - |